TBPH
NASDAQ · Pharmaceuticals
Theravance Biopharma Inc
$16.79
+0.05 (+0.30%)
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+48.6% upside
Low Target
$16.23
Average Target
$24.95
High Target
$30.59
Current Price
$16.79
Current
$16.79
$16.79
Target
$24.95
$24.95
$16.23
$24.95 avg
$30.59
Scenario Analysis
Bear Case
$16.23
-3.3%
Low target
Base Case
$24.95
+48.6%
Avg target
Bull Case
$30.59
+82.2%
High target
Risk/Reward
24.6x
Highly favorable
Price in Context
52-Week High
$21.03
-20.2% from high
52-Week Low
$8.33
+101.6% from low
Target vs 52W High
$24.95
+18.6% vs high
Peer Consensus — Pharmaceuticals